focus -WSS

focus

author：comprehensive 2025-09-05 06:45:22 - browse：89848

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Roche subsidiary Foundation Medicine opens new headquarters

focus

WSS

Decaf coffee targeted by food safety group under obscure FDA rule

Medical experts are missing from AI regulatory conversations

Trump got a 'target letter.' What is one and what does it mean?

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Decaf coffee targeted by food safety group under obscure FDA rule

leisure time

focus

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: Merck, Vertex, and Viking updates

Supreme Court strikes down use of affirmative action

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: Merck, Vertex, and Viking updates

Activists slam private health insurers over coverage restrictions

Covid vaccine financial winners and losers, from Pfizer to Novavax

In age of alternative facts, a scholarly course on calling out crap

Steward Health Care has deal to sell doctor network to UnitedHealth

hotspot

TikTok cracks down on users posting about weight loss drugs

Primary care physicians play key roles in Alzheimer's management

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Abortion pill Supreme Court ruling could impact entire drug industry

Patient advocates debate FDA's accelerated approval process

Study says nonprofit hospitals fall short in charity care spending

Wikipedia

focus

entertainment

hotspot